Unexpected hormonal activity of a catechol equine estrogen metabolite reveals reversible glutathione conjugation

Chemical Research in Toxicology

Volumn 23, Issue 8, 2010, Pages 1374-1383

  Peng, Kuan Wei ^a   Chang, Minsun ^b   Wang, Yue Ting ^a   Wang, Zhican ^a   Qin, Zhihui ^a   Bolton, Judy L ^a   Thatcher, Gregory R J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Sookmyung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYEQUILENIN; AROMATIC HYDROCARBON RECEPTOR; CARCINOGEN; CATECHOL; ESTROGEN; GLUTATHIONE; LUCIFERASE; QUINONE DERIVATIVE; THIOL; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DETOXIFICATION; GENE EXPRESSION; HORMONAL CARCINOGENESIS; HORMONAL REGULATION; HORMONE BINDING; HUMAN; HUMAN CELL; INCUBATION TIME;

ANIMALS; CELL PROLIFERATION; DNA, NEOPLASM; EQUILENIN; GLUTATHIONE; HORSES; HUMANS; LIGANDS; NADP; RECEPTORS, ESTROGEN; SULFHYDRYL COMPOUNDS; TUMOR CELLS, CULTURED;

EQUIDAE;

EID: 77955702259     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx100129h     Document Type: Article

References (59)

1. Liehr, J. G. (1990) Genotoxic effects of estrogens Mutat. Res. 238, 269-276
2. Colditz, G. A. (1998) Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer J. Natl. Cancer Inst. 90, 814-823
3. Feigelson, H. S. and Henderson, B. E. (1996) Estrogens and breast cancer Carcinogenesis 17, 2279-2284
4. Yager, J. D. and Davidson, N. E. (2006) Estrogen carcinogenesis in breast cancer N. Engl. J. Med. 354, 270-282
5. Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A., Howard, B. V., Johnson, K. C., Kotchen, J. M., and Ockene, J. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial J. Am. Med. Assoc. 288, 321-333
6. Beral, V. (2003) Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362, 419-427
7. Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., and Berry, D. A. (2007) The decrease in breast-cancer incidence in 2003 in the United States N. Engl. J. Med. 356, 1670-1674
8. Yager, J. D. (2000) (2000) Chapter 3: endogenous estrogens as carcinogens through metabolic activation J. Natl. Cancer Inst. Monogr. 67-73
9. Santen, R. J. (2002) To block estrogen's synthesis or action: that is the question J. Clin. Endocrinol. Metab. 87, 3007-3012
10. Bolton, J. L. and Thatcher, G. R. J. (2008) Potential mechanisms of estrogen quinone carcinogenesis Chem. Res. Toxicol. 21, 93-101
11. Cavalieri, E., Chakravarti, D., Guttenplan, J., Hart, E., Ingle, J., Jankowiak, R., Muti, P., Rogan, E., Russo, J., Santen, R., and Sutter, T. (2006) Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention Biochim. Biophys. Acta 1766, 63-78
12. Kim, S. H., Lee, S. U., Kim, M. H., Kim, B. T., and Min, Y. K. (2005) Mitogenic estrogen metabolites alter the expression of 17beta-estradiol- regulated proteins including heat shock proteins in human MCF-7 breast cancer cells Mol. Cells 20, 378-384
13. Li, J. J., Li, S. A., Oberley, T. D., and Parsons, J. A. (1995) Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation Cancer Res. 55, 4347-4351
14. Schutze, N., Vollmer, G., Tiemann, I., Geiger, M., and Knuppen, R. (1993) Catecholestrogens are MCF-7 cell estrogen receptor agonists J. Steroid Biochem. Mol. Biol. 46, 781-789
15. Schutze, N., Vollmer, G., and Knuppen, R. (1994) Catecholestrogens are agonists of estrogen receptor dependent gene expression in MCF-7 cells J. Steroid Biochem. Mol. Biol. 48, 453-461
16. Bolton, J. L. and Thatcher, G. R. (2008) Potential mechanisms of estrogen quinone carcinogenesis Chem. Res. Toxicol. 21, 93-101
17. Liu, X., Yao, J., Pisha, E., Yang, Y., Hua, Y., van Breemen, R. B., and Bolton, J. L. (2002) Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha Chem. Res. Toxicol. 15, 512-519
18. Chen, Y., Liu, X., Pisha, E., Constantinou, A. I., Hua, Y., Shen, L., van Breemen, R. B., Elguindi, E. C., Blond, S. Y., Zhang, F., and Bolton, J. L. (2000) A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines Chem. Res. Toxicol. 13, 342-350
19. Wang, Z., Wijewickrama, G. T., Peng, K. W., Dietz, B. M., Yuan, L., van Breemen, R. B., Bolton, J. L., and Thatcher, G. R. J. (2009) Estrogen receptor {alpha} enhances the rate of oxidative DNA damage by targeting an equine estrogen catechol metabolite to the nucleus J. Biol. Chem. 284, 8633-8642
20. Shen, L., Pisha, E., Huang, Z., Pezzuto, J. M., Krol, E., Alam, Z., van Breemen, R. B., and Bolton, J. L. (1997) Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity Carcinogenesis 18, 1093-1101
21. Jiang, S. Y. and Jordan, V. C. (1992) Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor J. Natl. Cancer Inst. 84, 580-591
22. Catherino, W. H. and Jordan, V. C. (1995) Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue Cancer Lett. 92, 39-47
23. Labarca, C. and Paigen, K. (1980) A simple, rapid, and sensitive DNA assay procedure Anal. Biochem. 102, 344-352
24. Xu, L. and Spink, D. C. (2008) Analysis of steroidal estrogens as pyridine-3-sulfonyl derivatives by liquid chromatography electrospray tandem mass spectrometry Anal. Biochem. 375, 105-114
25. Spink, D. C., Zhang, F., Hussain, M. M., Katz, B. H., Liu, X., Hilker, D. R., and Bolton, J. L. (2001) Metabolism of equilenin in MCF-7 and MDA-MB-231 human breast cancer cells Chem. Res. Toxicol. 14, 572-581
26. Chang, M., Peng, K.-w., Kastrati, I., Overk, C. R., Qin, Z.-H., Yao, P., Bolton, J. L., and Thatcher, G. R. J. (2007) Activation of estrogen receptor-mediated gene transcription by the equine estrogen Metabolite, 4-methoxyequilenin, in human breast cancer cells Endocrinology 148, 4793-480
27. Lavigne, J. A., Goodman, J. E., Fonong, T., Odwin, S., He, P., Roberts, D. W., and Yager, J. D. (2001) The effects of catechol-o-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells Cancer Res. 61, 7488-7494
28. Kraus, W. L., Montano, M. M., and Katzenellenbogen, B. S. (1994) Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene Mol. Endocrinol. 8, 952-969
29. Giamarchi, C., Solanas, M., Chailleux, C., Augereau, P., Vignon, F., Rochefort, H., and Richard-Foy, H. (1999) Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and-independent breast cancer cell lines Oncogene 18, 533-541
30. Levenson, A. S., Catherino, W. H., and Jordan, V. C. (1997) Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor J. Steroid Biochem. Mol. Biol. 60, 261-268
31. Klotz, D. M., Beckman, B. S., Hill, S. M., McLachlan, J. A., Walters, M. R., and Arnold, S. F. (1996) Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays Environ. Health Perspect. 104, 1084-1089
32. Soto, A. M., Sonnenschein, C., Chung, K. L., Fernandez, M. F., Olea, N., and Serrano, F. O. (1995) The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants Environ. Health Perspect. 103, 113-122
33. Katzenellenbogen, B. S., Choi, I., Delage-Mourroux, R., Ediger, T. R., Martini, P. G., Montano, M., Sun, J., Weis, K., and Katzenellenbogen, J. A. (2000) Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology J. Steroid Biochem. Mol. Biol. 74, 279-285
34. Levin, E. R. (2009) Plasma membrane estrogen receptors Trends Endocrinol. Metab. 20, 477-482
35. Prossnitz, E. R. and Maggiolini, M. (2009) Mechanisms of estrogen signaling and gene expression via GPR30 Mol. Cell. Endocrinol. 308, 32-38
36. Levenson, A. S., Kliakhandler, I. L., Svoboda, K. M., Pease, K. M., Kaiser, S. A., Ward, J. E., III, and and Jordan, V. C. (2002) Molecular classification of selective estrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing estrogen receptor a Br. J. Cancer 87, 449-456
37. Frasor, J., Stossi, F., Danes, J. M., Komm, B., Lyttle, C. R., and Katzenellenbogen, B. S. (2004) Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells Cancer Res. 64, 1522-1533
38. Wormke, M., Castro-Rivera, E., Chen, I., and Safe, S. (2000) Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells J. Steroid Biochem. Mol. Biol. 72, 197-207
39. Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., Yanagisawa, J., Fujii-Kuriyama, Y., and Kato, S. (2003) Modulation of oestrogen receptor signalling by association with the activated dioxin receptor Nature 423, 545-550
40. Shipley, J. M. and Waxman, D. J. (2006) Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene Toxicol. Appl. Pharmacol. 213, 87-97
41. Bhavnani, B. R. and Woolever, C. A. (1991) Interaction of ring B unsaturated estrogens with estrogen receptors of human endometrium and rat uterus Steroids 56, 201-210
42. Bhavnani, B. R., Tam, S. P., and Lu, X. (2008) Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta Endocrinology 149, 4857-4870
43. Oda, T., Tsuchiya, T., Sato, Y., and Yasukochi, Y. (1996) Estrogen receptor-mediated transcriptional activation by 17 beta-estradiol and its analogs Biol. Pharm. Bull. 19, 1018-1022
44. Chang, M., Shin, Y. G., van Breemen, R. B., Blond, S. Y., and Bolton, J. L. (2001) Structural and functional consequences of inactivation of human glutathione S-transferase P1-1 mediated by the catechol metabolite of equine estrogens, 4-hydroxyequilenin Biochemistry 40, 4811-4820
45. Liehr, J. G., Ricci, M. J., Jefcoate, C. R., Hannigan, E. V., Hokanson, J. A., and Zhu, B. T. (1995) 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis Proc. Natl. Acad. Sci. U.S.A. 92, 9220-9224
46. Liehr, J. G., Avitts, T. A., Randerath, E., and Randerath, K. (1986) Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer Proc. Natl. Acad. Sci. U.S.A. 83, 5301-5305
47. Newbold, R. R. and Liehr, J. G. (2000) Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens Cancer Res. 60, 235-237
48. Peng, K. W., Wang, H., Qin, Z., Wijewickrama, G. T., Lu, M., Wang, Z., Bolton, J. L., and Thatcher, G. R. (2009) Selective estrogen receptor modulator delivery of quinone warheads to DNA triggering apoptosis in breast cancer cells ACS Chem. Biol. 4, 1039-1049
49. Chang, M., Peng, K. W., Kastrati, I., Overk, C. R., Qin, Z. H., Yao, P., Bolton, J. L., and Thatcher, G. R. J. (2007) Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells Endocrinology 148, 4793-4802
50. Chang, M., Overk, C. R., Kastrati, I., Peng, K. W., Yao, P., Qin, Z. H., Petukhov, P., Bolton, J. L., and Thatcher, G. R. J. (2008) Estrogenic activity of the equine estrogen metabolite, 4-methoxyequilenin Adv. Exp. Med. Biol. 617, 601-607
51. Bolton, J. L., Yu, L., and Thatcher, G. R. J. (2004) Quinoids formed from estrogens and antiestrogens Methods Enzymol. 378, 110-123
52. Yao, J., Chang, M., Li, Y., Pisha, E., Liu, X., Yao, D., Elguindi, E. C., Blond, S. Y., and Bolton, J. L. (2002) Inhibition of cellular enzymes by equine catechol estrogens in human breast cancer cells: specificity for glutathione S-transferase P1-1 Chem. Res. Toxicol. 15, 935-942
53. Yao, J., Li, Y., Chang, M., Wu, H., Yang, X., Goodman, J. E., Liu, X., Liu, H., Mesecar, A. D., Van Breemen, R. B., Yager, J. D., and Bolton, J. L. (2003) Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase Chem. Res. Toxicol. 16, 668-675
54. Butterworth, M., Lau, S. S., and Monks, T. J. (1997) Formation of catechol estrogen glutathione conjugates and gamma-glutamyl transpeptidase- dependent nephrotoxicity of 17beta-estradiol in the golden Syrian hamster Carcinogenesis 18, 561-567
55. Thomas, M., Bader, C., and Monet, J. D. (1990) Sex steroid hormone modulation of NADPH pathways in MCF-7 cells Cancer Res. 50, 1195-1200
56. Sinha, B. K., Mimnaugh, E. G., Rajagopalan, S., and Myers, C. E. (1989) Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance Cancer Res. 49, 3844-3848
57. Khalife, K. H. and Lupidi, G. (2007) Nonenzymatic reduction of thymoquinone in physiological conditions Free Radical Res. 41, 153-161
58. Slot, A. J., Wise, D. D., Deeley, R. G., Monks, T. J., and Cole, S. P. (2008) Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites Drug Metab. Dispos. 36, 552-560
59. Chang, M., Zhang, F., Shen, L., Pauss, N., Alam, I., van Breemen, R. B., Blond, S. Y., and Bolton, J. L. (1998) Inhibition of glutathione S-transferase activity by the quinoid metabolites of equine estrogens Chem. Res. Toxicol. 11, 758-765